Astrazeneca Pharma India informs about compliances-certificate

09 Sep 2024 Evaluate
Astrazeneca Pharma India has enclosed the certificate dated September 4, 2024 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

6871.15 -159.20 (-2.26%)
15-Jan-2025 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1755.90
Dr. Reddys Lab 1340.50
Cipla 1445.00
Lupin 2122.80
Zydus Lifesciences 983.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.